🇪🇺 Hospital-Based Vaccination Pathway in European Union

Hospital-Based Vaccination Pathway (hospital-based-vaccination-pathway) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Hospital-Based Vaccination Pathway in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Hospital-Based Vaccination Pathway approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Hospital-Based Vaccination Pathway in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.